_256_384.jpg)
Medical Device | November 25, 2024
Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
If approved, Blenrep (belantamab mafodotin) in combinations with BorDex (BVd) and PomDex (BPd) could redefine multiple myeloma treatment at or after first relapse
The centre features a cutting-edge climatic chamber for stability testing and spectrophotometry to ensure that products meet the most stringent manufacturing and testing standards
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
HYMPAVZI’s approval is based on Phase 3 study results demonstrating non-inferiority and superiority compared to routine prophylaxis in eligible patients with hemophilia A or B without inhibitors
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
